PATENT CLAIM ANALYSIS

Application Number: 15747805
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-08
Patent Classification: ["514", "018600"]

Abstract:
The invention provides anti-fibrotic peptides derived from the C-terminal region of the MET receptor tyrosine kinase. Polynucleotides encoding these peptides, host cells transformed with the polynucleotides, and methods of using these peptides and polynucleotides are included in the invention. Uses of these peptides, polynucleotides and expression vectors include the treatment of fibrosis in a subject.

Claim (Index 18):
A method of negatively regulating TGF-\u03b2 signaling pathway in a cell, the method comprising contacting the cell with an effective amount of the peptide of  claim 1  or a polynucleotide encoding the peptide, thereby negatively regulating TGF-\u03b2 signaling pathway in a cell.

Metadata:
- Claim Count in Document: 17.0
- Percentile: 86.0
- Lexical Diversity: 1.5641
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14207246', '13939058', '13503339', '15385705', '10966845']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7786477973047434
- 35 USC 102 Novelty (BERT): 0.5293374226527314
- Combined Prediction Score: 0.7537167598395422
- Mean Citation Score: 313.782932
- Max Citation Score: 327.7170700000001
- Similarity Product: 175.12648927189952

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test